Xclair, a non-steroidal topical treatment designed to treat and relieve the symptoms of radiation dermatitis, is now available to community pharmacies, manufacturer Sinclair IS Pharma has said.

Xclair is registered as a medical device and contains: sodium hyaluronate, to moisturise and support collagen structure; temlesteine and vitis vinifera to inhibit skin-damaging enzymes released in response to injury; and shea butter to soften and protect skin.

The product is supported by peer-reviewed trials and can be used from the start of radiotherapy and after therapy has ceased to maintain skin condition.

A 50ml tube of Xclair has an NHS price of £17 and a shelf life of three years.